Citations

Clear

4207 citation(s) found for "Yu, Chen".

Augmented reality for the surgeon: Systematic review
Yoon, Jang W. , Chen, Robert E., Kim, Esther J. , Kerezoudis, Panagiotis , Han, Phillip K., Si, Phong, Diaz, Roberto J. , Komotar, Ricardo J. , Pirris, Stephen M. , Brown, Benjamin L. , Bydon, Mohamad , Wang, Michael Y. , Wharen, Robert E. , Quiñones‐Hinojosa, Alfredo , Akinduro, Oluwaseun O. , Freeman, William D.

Mayo Clinic

The International Journal of Medical Robotics and Computer Assisted Surgery | April 30, 2018 | Volume: 14 | Issue: 4 | Pages: No page available

10.1002/rcs.1914 | PMID 29708640 Get It

AbstractIntroductionSince the introduction of wearable head‐up displays, there has been much interest in the surgical community adapting this technology into routine surgical practice.MethodsWe used the keywords augmented reality OR wearable device OR head‐up display AND surgery using PubMed, EBSCO, IEEE and SCOPUS databases. After exclusions, 74 published articles that evaluated the utility of wearable head‐up displays in surgical settings were included in our review.ResultsAcross all studies, the most common use of head‐up displays was in cases of live streaming from surgical microscopes, navigation, monitoring of vital signs, and display of preoperative images. The most commonly used head‐up display was Google Glass. Head‐up displays enhanced surgeons' operating experience; common disadvantages include limited battery life, display size and discomfort.ConclusionsDue to ergonomic issues with dual‐screen devices, augmented reality devices with the capacity to overlay images onto the surgical field will be key features of next‐generation surgical head‐up displays.
Phase 1 study of the PI3Kδ inhibitor INCB040093 ± JAK1 inhibitor itacitinib in relapsed/refractory B-cell lymphoma
Forero‐Torres, Andres , Sher, Taimur , Diefenbach, Catherine , Johnston, Patrick B. , Talpaz, Moshe , Pulini, Jennifer, Zhou, Li , Scherle, Peggy , Chen, Xuejun , Phillips, Tycel , Barr, Paul M. , Talpaz, Moshe , Diefenbach, Catherine S

Mayo Clinic

Blood | April 25, 2018 | Volume: 132 | Issue: 3 | Pages: 293-306

10.1182/blood-2017-10-812701 | PMID 29695516 Get It

Key PointsINCB040093 was active across lymphoma subtypes, and the addition of itacitinib provided substantial activity in classic Hodgkin lymphoma. INCB040093 ± itacitinib had a manageable safety and tolerability profile; severe hepatic adverse effects were less common with the combination.
Colonization With Levofloxacin-resistant Extended-spectrum β-Lactamase-producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients
Satlin, Michael J. , Chavda, Kalyan D., Baker, Thomas, Shashkina, Elena, Soave, Rosemary, Small, Catherine B. , Jacobs, Samantha E, Westblade, Lars F. , Fowler, Vance G. , Jenkins, Stephen G., Walsh, Thomas J. , Kreiswirth, Barry N. , Jacobs, Samantha E. , Chen, Liang , Jacobs, Samantha E, Shore, Tsiporah B. , Besien, Koen van , Schuetz, Audrey N. , Fowler, Vance G. , Kreiswirth, Barry N

Mayo Clinic

Clinical Infectious Diseases | April 24, 2018 | Volume: 67 | Issue: 11 | Pages: 1720-1728

10.1093/cid/ciy363 | PMID 29701766 Get It

Abstract Background Bacteremia caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae (ESBL-E) is associated with inadequate empirical therapy and substantial mortality in neutropenic patients. Strategies are needed to identify neutropenic patients at high risk of these infections. Methods From April 2014 to September 2016, we collected perianal swabs, both at admission and weekly thereafter, from patients undergoing hematopoietic stem cell transplantation (HSCT). Patients received prophylactic levofloxacin while neutropenic. Swabs were plated onto selective agar, colonies were identified and underwent antimicrobial susceptibility testing, and phenotypic ESBL testing and polymerase chain reaction for β-lactamase genes were performed on ceftriaxone-resistant Enterobacteriaceae. We then determined the prevalence of pre-transplant ESBL-E colonization and risk of ESBL-E bacteremia. Colonizing and bloodstream isolates from patients with ESBL-E bacteremia underwent multilocus sequence typing and pulsed-field gel electrophoresis. Results We analyzed 312 patients, including 212 allogeneic and 100 autologous HSCT recipients. Ten percent (31/312) of patients had pre-transplant ESBL-E colonization. Susceptibility rates of colonizing ESBL-E were: levofloxacin, 25%; cefepime, 9%; piperacillin-tazobactam, 84%; and meropenem, 97%. Of 31 patients colonized with ESBL-E pre-transplant, 10 (32%) developed ESBL-E bacteremia during their transplant admission, compared to 1 (0.4%) of 281 patients not colonized with ESBL-E (P < .001). All bloodstream ESBL-E were levofloxacin-resistant and colonizing and bloodstream isolates from individual patients had identical genotypic profiles. Conclusions HSCT recipients who are colonized with levofloxacin-resistant ESBL-E pre-transplant and receive levofloxacin prophylaxis have high rates of bacteremia from their colonizing strain during neutropenia. Assessing for ESBL-E colonization in neutropenic patients could lead to optimization of empirical antibacterial therapy.
Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis
Shah, Nirav N. , Ahn, Kwang Woo , Litovich, Carlos, Fenske, Timothy S. , Ahmed, Sairah , Bejanyan, Nelli , Bolaños‐Meade, Javier , Chen, Andy I. , Ciurea, Stefan O. , Bachanová, Veronika , DeFilipp, Zachariah , Epperla, Narendranath , Farhadfar, Nosha , Herrera, Alex F. , Haverkos, Bradley M. , Holmberg, Leona , Hossain, Nasheed , Kharfan‐Dabaja, Mohamed A. , Kenkre, Vaishalee P. , Murthy, Hemant S. , Rezvani, Andrew R. , D’Souza, Anita , Ulrickson, Matthew L. , Waller, Edmund K. , Sureda, Anna , Smith, Sonali M. , Holmberg, Leona , Chen, Andy , Kharfan-Dabaja, Mohamed A., D'Souza, Anita , Bachanova, Veronika , Murthy, Hemant S , Waller, Edmund K , Epperla, Narendranath , Ahmed, Sairah , Battiwalla, Minoo , Dahi, Parastoo B , Lazarus, Hillard M. , Nishihori, Taiga , Savani, Bipin N. , Hamadani, Mehdi

Mayo Clinic

Blood Advances | April 23, 2018 | Volume: 2 | Issue: 8 | Pages: 933-940

10.1182/bloodadvances.2018018531 | PMID 29685953 Get It

Key Points There was no difference in overall survival after allogeneic transplant between patients aged 55-64 years and patients ≥65 years. Age alone should not be a determinant for allogeneic transplant eligibility among older non-Hodgkin lymphoma patients.
Single cardiac ventricular myosins are autonomous motors
Wang, Yihua , Yuan, Chen-Ching, Kaźmierczak, Katarzyna , Szczesna‐Cordary, Danuta , Burghardt, Thomas P. , Yuan, Chen‐Ching

Mayo Clinic

Open Biology | April 18, 2018 | Volume: 8 | Issue: 4 | Pages: 170240

10.1098/rsob.170240 | PMID 29669825 Get It

Myosin transduces ATP free energy into mechanical work in muscle. Cardiac muscle has dynamically wide-ranging power demands on the motor as the muscle changes modes in a heartbeat from relaxation, via auxotonic shortening, to isometric contraction. The cardiac power output modulation mechanism is explored in vitro by assessing single cardiac myosin step-size selection versus load. Transgenic mice express human ventricular essential light chain (ELC) in wild- type (WT), or hypertrophic cardiomyopathy-linked mutant forms, A57G or E143K, in a background of mouse α-cardiac myosin heavy chain. Ensemble motility and single myosin mechanical characteristics are consistent with an A57G that impairs ELC N-terminus actin binding and an E143K that impairs lever-arm stability, while both species down-shift average step-size with increasing load. Cardiac myosin in vivo down-shifts velocity/force ratio with increasing load by changed unitary step-size selections. Here, the loaded in vitro single myosin assay indicates quantitative complementarity with the in vivo mechanism. Both have two embedded regulatory transitions, one inhibiting ADP release and a second novel mechanism inhibiting actin detachment via strain on the actin-bound ELC N-terminus. Competing regulators filter unitary step-size selection to control force-velocity modulation without myosin integration into muscle. Cardiac myosin is muscle in a molecule.
Analysis of histologic follow‐up and risk of malignancy for salivary gland neoplasm of uncertain malignant potential proposed by the Milan System for Reporting Salivary Gland Cytopathology
Liu, Haiyan , Ljungren, Clarissa, Lin, Fan , Zarka, Matthew A., Chen, Longwen , Chen, Longwen

Mayo Clinic

Cancer Cytopathology | April 18, 2018 | Volume: 126 | Issue: 7 | Pages: 490-497

10.1002/cncy.22002 | PMID 29669190 Get It

BACKGROUNDThe Milan System for Reporting Salivary Gland Cytopathology is a tiered classification scheme that includes 6 diagnostic categories. Neoplasm, which is 1 of the 6 proposed categories, consists of benign neoplasm and neoplasm of uncertain malignant potential (NUMP). NUMP is reserved for a salivary gland neoplasm without clear distinction between benign and malignant. The objective of this study was to assess the risk of malignancy (ROM) of NUMP.METHODSA retrospective analysis was conducted on 656 salivary gland fine‐needle aspiration specimens from 2010 to 2016. Cases that qualified as NUMP and had follow‐up surgical resections were reviewed and reclassified into basaloid neoplasm (BN) and salivary gland neoplasm with predominant oncocytic cell (SGNOC) groups. The ROM for each group was calculated. Fifty‐four salivary gland fine‐needle aspirations of NUMP that had surgical follow‐up were identified, which included 29 BNs and 25 SGNOCs.RESULTSHistologic follow‐up for the BN group identified 14 cellular pleomorphic adenomas, 5 basal cell adenomas, 2 benign cystadenomas, 3 adenoid cystic carcinomas, 3 epithelial and myoepithelial carcinomas, 1 basal cell adenocarcinoma, and 1 myoepithelial carcinoma. Histologic follow‐up for the SGNOC group revealed 7 nodular oncocytoses, 6 Warthin tumors, 5 oncocytomas, 1 sebaceous adenoma, 1 mucinous cystadenoma, 2 acinic cell carcinomas, 2 mucoepidermoid carcinomas, and 1 mammary analog secretory carcinoma. The ROM was calculated at 24.1% for the NUMP category overall (27.6% for BNs and 20.0% for SGNOCs).CONCLUSIONSThe ROM of the SGNOC group is similar to that of the BN group but lower than the ROM (35%) proposed by the Milan system. Cancer Cytopathol 2018. © 2018 American Cancer Society.
Endosomal receptor trafficking: Retromer and beyond
Wang, Jing , Fedoseienko, Alina , Chen, Baoyu , Billadeau, Daniel D. , Billadeau, Daniel D , Burstein, Ezra , Jia, Da

Mayo Clinic

Traffic | April 18, 2018 | Volume: 19 | Issue: 8 | Pages: 578-590

10.1111/tra.12574 | PMID 29667289 Get It

The tubular endolysosomal network is a quality control system that ensures the proper delivery of internalized receptors to specific subcellular destinations in order to maintain cellular homeostasis. Although retromer was originally described in yeast as a regulator of endosome‐to‐Golgi receptor recycling, mammalian retromer has emerged as a central player in endosome‐to‐plasma membrane recycling of a variety of receptors. Over the past decade, information regarding the mechanism by which retromer facilitates receptor trafficking has emerged, as has the identification of numerous retromer‐associated molecules including the WASH complex, sorting nexins (SNXs) and TBC1d5. Moreover, the recent demonstration that several SNXs can directly interact with retromer cargo to facilitate endosome‐to‐Golgi retrieval has provided new insight into how these receptors are trafficked in cells. The mechanism by which SNX17 cargoes are recycled out of the endosomal system was demonstrated to involve a retromer‐like complex termed the retriever, which is recruited to WASH positive endosomes through an interaction with the COMMD/CCDC22/CCDC93 (CCC) complex. Lastly, the mechanisms by which bacterial and viral pathogens highjack this complex sorting machinery in order to escape the endolysosomal system or remain hidden within the cells are beginning to emerge. In this review, we will highlight recent studies that have begun to unravel the intricacies by which the retromer and associated molecules contribute to receptor trafficking and how deregulation at this sorting domain can contribute to disease or facilitate pathogen infection.
Spatiotemporal clutter filtering methods for in vivo microvessel imaging
Song, Pengfei , Song, Pengfei , Chen, Shigao

Mayo Clinic

The Journal of the Acoustical Society of America | April 17, 2018 | Volume: 143 | Issue: 3_Supplement | Pages: 1900-1900

10.1121/1.5036186 Get It

Ultrafast plane wave imaging enables acquisition and accumulation of a large number of Doppler ensembles in a short period of time, which substantially boosts ultrasound Doppler sensitivity by at least an order of magnitude. As a key component, spatiotemporal clutter filtering based on singular value decomposition (SVD) has recently demonstrated superior performance in tissue clutter suppression and microvessel signal extraction over conventional high-pass-filter-based clutter filtering techniques. This presentation introduces several novel SVD clutter filter techniques from our recent work, focusing on addressing the technical challenges (complex tissue motion, high computational cost, and noise) of SVD clutter filter during clinical translations of the ultrafast microvessel imaging technology for human imaging. We present a block-wise adaptive SVD filter method that can robustly threshold singular values on a local level, a real-time feasible SVD clutter filtering method based on partial SVD and randomized spatial downsampling, and a noise equalization and suppression method that can significantly improve microvessel imaging quality at a low cost. In vivo performance of these methods will be demonstrated in different organs.
B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease
Redfors, Björn , Crowley, Aaron , Ben‐Yehuda, Ori , Lembo, Nicholas , Brown, W. Morris, Banning, Adrian , Sabik, Joseph F. , Stone, Gregg W. , Serruys, Patrick W , Chen, Shmuel , Gersh, Bernard J. , Taggart, David P , Serruys, Patrick W. , Kappetein, A. Pieter , Banning, Adrian

Mayo Clinic

Circulation | April 17, 2018 | Volume: 138 | Issue: 5 | Pages: 469-478

10.1161/circulationaha.118.033631 | PMID 29666071 Get It

Background: Elevated B-type natriuretic peptide (BNP) is reflective of impaired cardiac function and is associated with worse prognosis among patients with coronary artery disease (CAD). We sought to assess the association between baseline BNP, adverse outcomes, and the relative efficacy of percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) in patients with left main CAD. Methods: The EXCEL trial (Evaluation of XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) randomized patients with left main CAD and low or intermediate SYNTAX scores (Synergy Between PCI With TAXUS and Cardiac Surgery) to PCI with everolimus-eluting stents versus CABG. The primary end point was the composite of all-cause death, myocardial infarction, or stroke. We used multivariable Cox proportional hazards regression to assess the associations between normal versus elevated BNP (≥100 pg/mL), randomized treatment, and the 3-year risk of adverse events. Results: BNP at baseline was elevated in 410 of 1037 (39.5%) patients enrolled in EXCEL. Patients with elevated BNP levels were older and more frequently had additional cardiovascular risk factors and lower left ventricular ejection fraction than those with normal BNP, but had similar SYNTAX scores. Patients with elevated BNP had significantly higher 3-year rates of the primary end point (18.6% versus 11.7%; adjusted hazard ratio [HR], 1.62; 95% confidence interval [CI], 1.16–2.28; P =0.005) and higher mortality (11.5% versus 3.9%; adjusted HR, 2.49; 95% CI, 1.48–4.19; P =0.0006), both from cardiovascular and noncardiovascular causes. In contrast, there were no significant differences in the risks of myocardial infarction, stroke, ischemia-driven revascularization, stent thrombosis, graft occlusion, or major bleeding. A significant interaction ( P interaction =0.03) was present between elevated versus normal BNP and treatment with PCI versus CABG for the adjusted risk of the primary composite end point at 3 years among patients with elevated BNP (adjusted HR for PCI versus CABG, 1.54; 95% CI, 0.96–2.47) versus normal BNP (adjusted HR, 0.74; 95% CI, 0.46–1.20). This interaction was stronger when log(BNP) was modeled as a continuous variable ( P interaction =0.002). Conclusions: In the EXCEL trial, elevated baseline BNP levels in patients with left main CAD undergoing revascularization were independently associated with long-term mortality but not nonfatal adverse ischemic or bleeding events. The relative long-term outcomes after PCI versus CABG for revascularization of left main CAD may be conditioned by the baseline BNP level. Clinical Trial Registration: URL: https://www.clinicaltrials.gov . Unique identifier: NCT01205776.
The PINK1 p.I368N Mutation Affects Protein Stability and Kinase Activity with Its Structural Change
Ando, Maya , Hudec, Roman, Ogaki, Kotaro, Górka-Skoczylas, Paulina , Dawson, Ted M. , Fiesel, Fabienne C. , Caulfield, Thomas R. , Koziorowski, Dariusz , Friedman, Andrzej , Chen, Li , Dawson, Valina L. , Bu, Guojun , Ross, Owen A. , Wszołek, Zbigniew K. , Springer, Wolfdieter

Mayo Clinic

Juntendo Medical Journal | April 15, 2018 | Volume: 64 | Issue: 1 | Pages: 17-30

10.14789/jmj.2018.64.jmjjmj17-r10 Get It